SCHEMBL17567348

SCHEMBL17567348

c1ccc(-c2ccc(N(c3cccc(-c4ccccc4)c3)c3cccc(-c4ccc(N(c5cccc(-c6ccccc6)c5)c5ccccc5-c5ccccc5)cc4)c3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.37
MAPT P10636 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ATM Q13315 2/20 0.36
NPC1 O15118 2/20 0.36
APAF1 O14727 1/20 0.36
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
XBP1 P17861 1/20 0.36
PTBP1 P26599 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23437377 1.00 L3MBTL1 (0.37) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL17705330 1.00 L3MBTL1 (0.37) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL17567344 1.00 L3MBTL1 (0.37) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL17567346 1.00 L3MBTL1 (0.37) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL15038387 0.98 MAPT (0.37) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL15038386 0.97 ACMSD (0.37) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL19998698 0.97 ACMSD (0.37) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL16385734 0.97 ACMSD (0.37) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL17471805 0.95 L3MBTL1 (0.38) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL22259409 0.95 L3MBTL1 (0.38) L3MBTL1MAPTALDH1A1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160072091-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-03-10 US disclosed
US-20160072091-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-03-10 US disclosed
US-20150133653-A1 COMPOUNDS AND BIOLOGICAL MATERIALS AND USES THEREOF PHOTOBIOTICS LIMITED (GB) 2015-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150133653-A1 COMPOUNDS AND BIOLOGICAL MATERIALS AND USES THEREOF SSB, HLA-B, BDKRB1 L3MBTL1 1047/4885MAPT 2363/4885ALDH1A1 371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.